(S)-4-Benzyl-2-((benzyloxy)methyl)-1,4-oxazepane, 98%, 250mg

1-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)ETHANAMINE HCL, 95.0%, 250mg

3-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid, 95.0%, 10g

6-Bromo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 98%, 5g

1-Chloro-2-methylpentane>98.0%(GC)5g

CAPS, 25 g

1-(2-propyn-1-yl)piperazine, 95.0%, 250mg

2-Bromo-4-chloro-5-methylpyridine, 95.0%, 2.5g

5-(4-Methoxy-benzyl)-4-methyl-4H-[1,2,4]triazole-3-thiol, 1g

(4-Fluoro-3-nitrophenyl)methanamine hydrochloride, 95.0%, 1g

3,3-DIFLUOROPIPERIDINE-4,4-DIOL HCL, 95.0%, 250mg

Electroporation cuvettes 850 µl, 10 pcs 10 pcs

5-bromo-1H-pyrazolo[3,4-b]pyridine, 98%, 10g